Skip navigation
Agenda

Tracking Emerging State Price Transparency, Reporting & Disclosure Laws to Ensure Compliance

September 27, 2018
  • Philadelphia, PA

Agenda

Want more agenda details? Download the brochure.

SEPTEMBER 27, 2018

7:30

Registration and Continental Breakfast

8:15

Chairperson’s Welcome and Opening Remarks

Sabrina Yohai
Vice President, Policy, Access & Value, Corporate Legal
Vertex Pharmaceuticals Inc.

8:30

State Drug Pricing Reporting Requirements and Interpretations —
What You Need to Know Now to Ensure Reporting Compliance

Trevor L. Wear
Partner
Sidley Austin LLP

9:30

Federal Legislative Activity — American Patients First Update

Seth Lundy
Partner
King & Spalding LLP

10:15

Implications of State Drug Pricing Transparency Laws on Policy

MODERATOR:

Vince Sampson
Partner
Cooley LLP

PANELISTS:

Joanne Chan
Assistant General Counsel
Pharmaceutical Research and Manufacturers of America (PhRMA)

Kendra Martello
Senior Director, Public Policy, Government Affairs & Public Policy
Mallinckrodt Pharmaceuticals

11:15

Networking and Refreshment Break

11:45

California SB-17 — Implementation and Enforcement Update

Sarah diFrancesca
Partner
Cooley LLP

12:15

Oregon HB 4005 — Reporting Requirements Overview and Update

Trevor L. Wear
Partner
Sidley Austin LLP

12:45

Networking Luncheon

1:30

Operational Best Practices Focused on Governance and Planning for the Future

Andrew Parks
Director
KPMG

2:15

PANEL DISCUSSION:The Impact of Transparency and Disclosure Legislation on Legal and Compliance Practices

MODERATOR:

Brian A. Bohnenkamp
Partner, FDA & Life Sciences Practice
King & Spalding LLP

PANELISTS:

Debbie A. Walters
Vice President, Assistant General Counsel
Pfizer Inc

Sabrina Yohai
Vice President, Policy, Access & Value, Corporate Legal
Vertex Pharmaceuticals Inc.

3:15

Networking and Refreshment Break

3:45

The Latest Developments for New York’s Medicaid Drug Cap and the Impact of ICER on Drug Pricing

Jonathan Connell, JD, MBA
Senior Counsel
Bristol-Myers Squibb

4:30

Chairperson’s Closing Remarks

4:45

Close of Conference

Networking, Wine and Cheese Reception
Immediately following the final session

Agenda

Want more agenda details? Download the brochure.

Want more agenda details? Download the brochure.

SEPTEMBER 27, 2018

7:30

Registration and Continental Breakfast

8:15

Chairperson’s Welcome and Opening Remarks

Sabrina Yohai
Vice President, Policy, Access & Value, Corporate Legal
Vertex Pharmaceuticals Inc.

8:30

State Drug Pricing Reporting Requirements and Interpretations —
What You Need to Know Now to Ensure Reporting Compliance

Trevor L. Wear
Partner
Sidley Austin LLP

9:30

Federal Legislative Activity — American Patients First Update

Seth Lundy
Partner
King & Spalding LLP

10:15

Implications of State Drug Pricing Transparency Laws on Policy

MODERATOR:

Vince Sampson
Partner
Cooley LLP

PANELISTS:

Joanne Chan
Assistant General Counsel
Pharmaceutical Research and Manufacturers of America (PhRMA)

Kendra Martello
Senior Director, Public Policy, Government Affairs & Public Policy
Mallinckrodt Pharmaceuticals

11:15

Networking and Refreshment Break

11:45

California SB-17 — Implementation and Enforcement Update

Sarah diFrancesca
Partner
Cooley LLP

12:15

Oregon HB 4005 — Reporting Requirements Overview and Update

Trevor L. Wear
Partner
Sidley Austin LLP

12:45

Networking Luncheon

1:30

Operational Best Practices Focused on Governance and Planning for the Future

Andrew Parks
Director
KPMG

2:15

PANEL DISCUSSION:The Impact of Transparency and Disclosure Legislation on Legal and Compliance Practices

MODERATOR:

Brian A. Bohnenkamp
Partner, FDA & Life Sciences Practice
King & Spalding LLP

PANELISTS:

Debbie A. Walters
Vice President, Assistant General Counsel
Pfizer Inc

Sabrina Yohai
Vice President, Policy, Access & Value, Corporate Legal
Vertex Pharmaceuticals Inc.

3:15

Networking and Refreshment Break

3:45

The Latest Developments for New York’s Medicaid Drug Cap and the Impact of ICER on Drug Pricing

Jonathan Connell, JD, MBA
Senior Counsel
Bristol-Myers Squibb

4:30

Chairperson’s Closing Remarks

4:45

Close of Conference

Networking, Wine and Cheese Reception
Immediately following the final session